Achieve Life Sciences: Could Be The Best 'Tobacco' Stock For 2026 - Strong Buy
Source: SeekingAlpha
2026-02-04 02:43:16 ET
Intro
Achieve Life Sciences ( ACHV ) is a pre-commercial, late-stage pharmaceutical company that develops a smoking and vaping cessation therapy. It currently has no sales-generating business, as it is awaiting the FDA’s decision on whether its drug candidate Cytisinicline will be given the green light in about four months in June. If approved for smoking cessation later this year, it would be the first of its kind since 2006 , i.e., exactly 20 years....
Read the full article on Seeking Alpha
For further details see:
Achieve Life Sciences: Could Be The Best 'Tobacco' Stock For 2026 - Strong Buy
Achieve Life Sciences Inc.
NASDAQ: ACHV
ACHV Trading
4.47% G/L:
$5.37 Last:
453,265 Volume:
$5.35 Open:
ACHV Latest News
May 19, 2026 02:15:00 pm
Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment
May 12, 2026 07:05:00 am
Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma
May 12, 2026 07:00:00 am
Achieve Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Updates
ACHV Stock Data
$234,761,887
51,636,968
N/A
28
N/A
Biotechnology & Life Sciences
Healthcare
CA
Bothell
